authors
- Salloway, Stephen P
- Liu, Enchi
- Carr, Stephen
- Black, Ronald S
- Brashear, H Robert
- Reisa Sperling, MD
- Fox, Nick C
- Sabbagh, Marwan N
- Honig, Lawrence S
- Porsteinsson, Anton P
- Rofael, Hany
- Ketter, Nzeera
- Wang, Daniel
Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- 2018
published in
has subject area
- Aged
- Aged, 80 and over
- Alzheimer Disease
- Antibodies, Monoclonal, Humanized
- Antipsychotic Agents
- Apolipoproteins E
- Brain
- Double-Blind Method
- Female
- Humans
- Longitudinal Studies
- Male
- Middle Aged
- Neuroimaging
- Psychiatric Status Rating Scales
- Retrospective Studies
- Time Factors
- Treatment Outcome
- tau Proteins